Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating

Molecular Pharmacology

Volumn 59, Issue 6, 2001, Pages 1376-1387

  Rybalchenko, V ^a   Prevarskaya, N ^a   Van Coppenolle, F ^a   Legrand, G ^a   Lemonnier, L ^a   Le Bourhis, X ^a   Skryma, R ^a  

^a Université des Sciences et Technologies de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYLVERAPAMIL; PHENYLALKYLAMINE; POTASSIUM CHANNEL; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; BINDING SITE; CANCER CELL; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CHANNEL GATING; CONDUCTANCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MEMBRANE BINDING; MEMBRANE POTENTIAL; PATCH CLAMP; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0034984899     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.6.1376     Document Type: Article

References (36)

1. Ion channels and B cell mitogenesis
2. Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells
3. + channels by TEA and class III antiarrhythmics-evidence against a single drug-sensitive channel site
4. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
5. Mechanism of verapamil block of a neuronal delayed rectifier K channel: Active form of the blocker and location of its binding domain
6. + channel block by verapamil and related compounds in rat alveolar epithelial cells
7. UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation
8. Mechanisms of verapamil inhibition of action potential firing in rat intracardiac ganglion neurons
9. Benign prostatic hyperplasia: New insights (editorial)
10. Antagonistic effect of androgen on prostatic cell death
11. The system of double inhibitions
12. + channels and the intracellular calcium signal in human melanoma cell proliferation
13. Identification of ether a go-go and calcium-activated potassium channels in human melanoma cells
14. Potassium channels and regulation of proliferation of human melanoma cells
15. + conductance and cell proliferation in small-cell lung cancer
16. Blockers of voltage-gated K channels inhibit proliferation of cultured brown fat cells
17. + channels
18. Potassium conductance of smooth muscle cells from rabbit aorta in primary culture
19. Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3
20. The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel
21. + channels and their functions in small dorsal root ganglion neurones of rat
22. + channel from mammalian spermatocytes
23. Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: Involvement in cell proliferation
24. 2+ channels in Chinese hamster ovary (CHO) cells
25. 2+ current in human prostate cancer LNCaP cells; involvement in apoptosis
26. 2+-inhibited potassium channels in the LNCaP human prostate cancer cell line
27. Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line
28. + channel currents in the basolateral membrane of villus enterocytes isolated from guinea pig small intestine
29. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines
30. Verapamil block of the delayed rectifier K current in chick embryo dorsal root ganglion neurons
31. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins
32. + channels expressed in xenopus oocytes
33. K-current mediation of prolactin-induced proliferation of malignant (Nb2) lymphocytes
34. Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes
35. 2+ influx in carcinoma cells of colon cancer
36. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels